Intellia Therapeutics Inc (NTLA)
21.74
-0.24
(-1.09%)
USD |
NASDAQ |
Apr 30, 10:25
Intellia Therapeutics Price: 21.74 for April 30, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 29, 2024 | 21.06 | 22.40 | 21.06 | 21.98 | 1.325M |
| Apr 26, 2024 | 20.11 | 20.98 | 19.37 | 20.76 | 1.026M |
| Apr 25, 2024 | 20.53 | 20.66 | 19.64 | 20.02 | 1.460M |
| Apr 24, 2024 | 21.56 | 21.73 | 21.03 | 21.17 | 859470.0 |
| Apr 23, 2024 | 21.78 | 22.85 | 21.50 | 21.53 | 849473.0 |
| Apr 22, 2024 | 21.77 | 22.20 | 20.88 | 21.83 | 1.024M |
| Apr 19, 2024 | 21.22 | 21.63 | 20.78 | 21.57 | 1.457M |
| Apr 18, 2024 | 21.37 | 21.86 | 21.18 | 21.32 | 1.145M |
| Apr 17, 2024 | 21.94 | 22.13 | 21.44 | 21.50 | 1.077M |
| Apr 16, 2024 | 22.62 | 22.84 | 21.80 | 21.81 | 1.231M |
| Apr 15, 2024 | 24.13 | 24.15 | 22.51 | 22.92 | 1.559M |
| Apr 12, 2024 | 24.83 | 24.98 | 23.96 | 24.27 | 1.296M |
| Apr 11, 2024 | 25.29 | 25.53 | 24.42 | 25.01 | 1.408M |
| Apr 10, 2024 | 24.76 | 25.19 | 24.38 | 24.95 | 1.611M |
| Apr 09, 2024 | 25.46 | 26.24 | 25.33 | 26.08 | 901450.0 |
| Apr 08, 2024 | 24.75 | 25.49 | 24.75 | 25.30 | 1.138M |
| Apr 05, 2024 | 24.54 | 25.26 | 24.34 | 24.78 | 879766.0 |
| Apr 04, 2024 | 25.32 | 25.56 | 24.75 | 24.97 | 1.210M |
| Apr 03, 2024 | 25.00 | 25.55 | 24.34 | 24.98 | 1.164M |
| Apr 02, 2024 | 26.38 | 26.38 | 25.07 | 25.10 | 1.932M |
| Apr 01, 2024 | 27.43 | 27.46 | 26.60 | 27.22 | 878671.0 |
| Mar 28, 2024 | 26.98 | 28.23 | 26.61 | 27.51 | 1.054M |
| Mar 27, 2024 | 26.50 | 27.46 | 26.06 | 27.02 | 1.201M |
| Mar 26, 2024 | 27.19 | 27.55 | 26.20 | 26.26 | 978523.0 |
| Mar 25, 2024 | 26.95 | 27.34 | 26.74 | 26.83 | 733792.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
9.44
Minimum
Mar 16 2020
176.78
Maximum
Sep 03 2021
48.89
Average
38.18
Median
Price Benchmarks
| Moderna Inc | 111.92 |
| Regeneron Pharmaceuticals Inc | 895.03 |
| NeuroMetrix Inc | 4.69 |
| Repligen Corp | 167.44 |
| Pacific Biosciences of California Inc | 1.655 |
Price Related Metrics
| PS Ratio | 53.58 |
| Price to Book Value | 1.990 |
| Earnings Yield | -24.89% |
| Market Cap | 2.089B |